Abstracts

LONGITUDINAL ASSESSMENT OF VIRAL SHEDDING AMONG PATIENTS WITH MPOX IN TORONTO, CANADA

Background: Patients with human Mpox infection may have detectable virus in multiple anatomic compartments including skin, mucosal sites, blood, urine and semen. Longitudinal data on viral shedding are scarce. Methods: We conducted a prospective cohort study of adults with confirmed or suspected Mpox infection at an academic hospital in Toronto, Canada. Participants underwent swabs of…

PROTECTION AGAINST HETEROLOGOUS CHALLENGE 1 YEAR AFTER INFANT SARS-CoV-2 IMMUNIZATION

Background: Although mRNA SARS-CoV-2 vaccines have received emergency-use-authorization for infants age 6 months and older, vaccine uptake is slow, stressing that questions of safety and durability of vaccine efficacy remain prominent. Methods: Infant rhesus macaques (RMs) (n=8/group) at 2 months of age, comparable to human toddler age, were immunized intramuscularly at weeks 0 and 4…

MITIGATING THE IMPACT OF COVID-19 ON HIV VIRAL LOAD ACCESS AMONG KEY POPULATIONS

Background: Monitoring of HIV-infected individuals on antiretroviral treatment requires periodic viral load(VL) measurements to ascertain adequate response to treatment. While plasmaVL is widely available in health facilities, it is difficult for use among key populations(KPs) due to their high mobility and sophisticated sample storage and transport requirements, which are not available for community VL sample…

IDENTIFYING PREFERRED PROGRAM DELIVERY ATTRIBUTES FOR LONG-ACTING INJECTABLE ART

Background: As long-acting injectable antiretroviral therapy (LAI-ART) enters clinical practice, it is crucial to incorporate patient preferences into the design of LAI-ART delivery programs, especially among underserved people living with HIV (PLWH). Methods: Using formative qualitative research, we developed a tablet-based discrete choice experiment (DCE) for administration in three urban HIV clinics (UCSF’s Ward 86,…

INCIDENCE OF ACQUIRED INTEGRASE RESISTANCE AFTER TRANSITION TO DOLUTEGRAVIR IN UGANDA

Background: Millions of people with HIV in sub-Saharan Africa have been switched from non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy (ART) to tenofovir-lamivudine-dolutegravir (TLD) since 2018. Whereas clinical trials have rarely documented resistance to TLD after switch, limited programmatic data are available to estimate the incidence of acquired drug resistance on TLD in the region.…

RECONSTRUCTION OF THE ADCC ANTIBODY REPERTOIRE OF AN HIV-1 NON-TRANSMITTING MOTHER

Background: Evidence from animal and human studies supports a role for Fc-mediated antibody (Ab) effector functions in protection from HIV acquisition and/or pathogenesis. In the setting of vertical transmission, passively-transferred Abs that mediate antibody-dependent cellular cytotoxicity (ADCC) correlate with reduced transmission, as well as improved clinical outcome in infants that acquire HIV. The characteristics of…

EXCESS OF MORTALITY IN OLDER PEOPLE DURING THE COVID-19 PANDEMIC IN MOZAMBIQUE

Background: The impact of COVID-19 pandemic was apparently less severe in African continents, probably underestimated due to the limited testing capacities and access to health facilities, particularly in rural areas. Hospital and community surveillance of COVID-19 was established in Manhiça District, rural Mozambique to understand the epidemic curve and natural history of SARS-CoV-2 including age-specific…